Ignite Creation Date:
2025-12-25 @ 12:32 AM
Ignite Modification Date:
2026-05-31 @ 7:25 AM
Study NCT ID:
NCT00346567
Status:
COMPLETED
Last Update Posted:
2016-02-23
First Post:
2006-06-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Backup With Combivir or Single Dose (SD) Truvada in Order to Avoid Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) Resistance After SD Nevirapine for the Prevention of Mother-to-child Transmission (PMTCT)
Sponsor:
Rigshospitalet, Denmark
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
comtru
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Terese Katzenstein Consultant, MD, Ph.D. DMSc
Old Organization:
Rigshospitalet
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |